These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36802727)

  • 41. Hypomethylation of lncRNA H19 as a potential prognostic biomarker for oral squamous cell carcinoma.
    Lee EY; Song JM; Kim HJ; Park HR
    Arch Oral Biol; 2021 Sep; 129():105214. PubMed ID: 34333230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Downregulation of lncRNA H19 sensitizes melanoma cells to cisplatin by regulating the miR-18b/IGF1 axis.
    An LF; Huang JW; Han X; Wang J
    Anticancer Drugs; 2020 Jun; 31(5):473-482. PubMed ID: 32265386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CCL18-induced LINC00319 promotes proliferation and metastasis in oral squamous cell carcinoma via the miR-199a-5p/FZD4 axis.
    Jiang X; Liu J; Li S; Jia B; Huang Z; Shen J; Luo H; Zhao J
    Cell Death Dis; 2020 Sep; 11(9):777. PubMed ID: 32948745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LncRNA H19-elevated LIN28B promotes lung cancer progression through sequestering miR-196b.
    Ren J; Fu J; Ma T; Yan B; Gao R; An Z; Wang D
    Cell Cycle; 2018; 17(11):1372-1380. PubMed ID: 29950144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
    Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The LncRNA H19/miR-193a-3p axis modifies the radio-resistance and chemotherapeutic tolerance of hepatocellular carcinoma cells by targeting PSEN1.
    Ma H; Yuan L; Li W; Xu K; Yang L
    J Cell Biochem; 2018 Nov; 119(10):8325-8335. PubMed ID: 29968942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exosomal lncRNA-H19 promotes osteogenesis and angiogenesis through mediating Angpt1/Tie2-NO signaling in CBS-heterozygous mice.
    Behera J; Kumar A; Voor MJ; Tyagi N
    Theranostics; 2021; 11(16):7715-7734. PubMed ID: 34335960
    [No Abstract]   [Full Text] [Related]  

  • 49. lncRNA H19 contributes to oxidative damage repair in the early age-related cataract by regulating miR-29a/TDG axis.
    Cheng T; Xu M; Qin B; Wu J; Tu Y; Kang L; Wang Y; Guan H
    J Cell Mol Med; 2019 Sep; 23(9):6131-6139. PubMed ID: 31282110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI.
    Zhu M; Chen Q; Liu X; Sun Q; Zhao X; Deng R; Wang Y; Huang J; Xu M; Yan J; Yu J
    FEBS J; 2014 Aug; 281(16):3766-75. PubMed ID: 24988946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiRNA-200c, MiRNA-139 and ln RNA H19; new predictors of treatment response in H-pylori- induced gastric ulcer or progression to gastric cancer.
    Schaalan M; Mohamed W; Fathy S
    Microb Pathog; 2020 Dec; 149():104442. PubMed ID: 32795593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Huaier Extract Inhibits Breast Cancer Progression Through a LncRNA-H19/MiR-675-5p Pathway.
    Wang J; Wang X; Chen T; Jiang L; Yang Q
    Cell Physiol Biochem; 2017; 44(2):581-593. PubMed ID: 29145193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo self-assembled small RNA targets H19 lncRNA for the treatment of colorectal cancer.
    Sun Y; Zhao Y; Ni X; Yang Y; Fu Z; Liu R; Zhang CY; Chen X
    J Control Release; 2023 Jun; 358():142-160. PubMed ID: 37068521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long Noncoding RNA H19-Derived miR-675 Enhances Proliferation and Invasion via RUNX1 in Gastric Cancer Cells.
    Liu G; Xiang T; Wu QF; Wang WX
    Oncol Res; 2016; 23(3):99-107. PubMed ID: 26931432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. H19 promotes the migration and invasion of colon cancer by sponging miR-138 to upregulate the expression of HMGA1.
    Yang Q; Wang X; Tang C; Chen X; He J
    Int J Oncol; 2017 May; 50(5):1801-1809. PubMed ID: 28358427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long non-coding RNA H19 promotes glucose metabolism and cell growth in malignant melanoma via miR-106a-5p/E2F3 axis.
    Luan W; Zhou Z; Ni X; Xia Y; Wang J; Yan Y; Xu B
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):531-542. PubMed ID: 29350287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA SBF2-AS1: A Budding Star in Various Cancers.
    Tan F; Chen J; Wang B; Du Z; Mou J; Wu Y; Liu Y; Zhao F; Yuan C
    Curr Pharm Des; 2022; 28(18):1513-1522. PubMed ID: 35440300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The expression profiling of circulating miR-204, miR-182, and lncRNA H19 as novel potential biomarkers for the progression of peptic ulcer to gastric cancer.
    Mohamed WA; Schaalan MF; Ramadan B
    J Cell Biochem; 2019 Aug; 120(8):13464-13477. PubMed ID: 30945348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.